GOPTEN

Main information

  • Trade name:
  • GOPTEN Capsule, hard 2MG
  • Dosage:
  • 2MG
  • Pharmaceutical form:
  • Capsule, hard
  • Administration route:
  • Oral use
  • Units in package:
  • 84 Blister
  • Prescription type:
  • with prescription
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • GOPTEN Capsule, hard 2MG
    Czech Republic
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • TRANDOLAPRIL
  • Product summary:
  • GOPTEN

Other information

Status

  • Source:
  • SUKL - Státní ústav pro kontrolu léčiv
  • Authorization status:
  • B - medicinal product after change, may be placed on the market
  • Authorization number:
  • 58/ 067/95-B/C
  • Last update:
  • 16-01-2018

There are no safety alerts related to this product.

28-11-2018


Opinion/decision on a Paediatric investigation plan (PIP): trandolapril, decision type: , therapeutic area: , PIP number: P/0192/2018

Opinion/decision on a Paediatric investigation plan (PIP): trandolapril, decision type: , therapeutic area: , PIP number: P/0192/2018

Opinion/decision on a Paediatric investigation plan (PIP): trandolapril, decision type: , therapeutic area: , PIP number: P/0192/2018

Europe - EMA - European Medicines Agency

28-11-2018


Opinion/decision on a Paediatric investigation plan (PIP): Verapamil / trandolapril, decision type: , therapeutic area: , PIP number: P/0162/2018

Opinion/decision on a Paediatric investigation plan (PIP): Verapamil / trandolapril, decision type: , therapeutic area: , PIP number: P/0162/2018

Opinion/decision on a Paediatric investigation plan (PIP): Verapamil / trandolapril, decision type: , therapeutic area: , PIP number: P/0162/2018

Europe - EMA - European Medicines Agency